Camber adds 5 mg strength to their Baclofen portfolio
Piscataway, NJ, August 2, 2021– Camber Pharmaceuticals is pleased to announce that it has added the 5 mg strength to their current product portfolio for Baclofen Tablets, which is the generic version of Lioresal®
Baclofen Tablets are used to treat muscle pain, spasms, and stiffness in people with multiple sclerosis or spinal cord injury or disease.
Baclofen Tablets from Camber is now available in 5 mg strength as well as 10mg- 100 and 1000ct bottles and 20mg- 100, 500 and 1000ct bottles.
Camber Pharmaceuticals is a fully integrated international pharmaceutical company that maintains quality and integrity in all its products. Its parent company, Hetero Drugs of Hyderabad India, is one of the world’s leading API and finished dosage manufacturers. Camber’s commitment to the consumer is to bring the highest quality generic pharmaceuticals to the market to improve quality of life through cost-effective medications.
# # #
If you would like more information about this topic, please contact Megan Little at [email protected].
Recent articles
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class
- Camber Launches 5 Generics in May






